Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway
Author:
Affiliation:
1. Department of Urology The Third Affiliated Hospital of Soochow University Changzhou People's Republic of China
2. Department of Urology Peking University Third Hospital Beijing People's Republic of China
Funder
China Postdoctoral Science Foundation
Publisher
Wiley
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2403
Reference32 articles.
1. Global cancer statistics, 2012
2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
3. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
4. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives
5. Systemic Therapy for Metastatic Renal-Cell Carcinoma
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study;Health Science Reports;2023-12
2. “Alphabet” Selenoproteins: Their Characteristics and Physiological Roles;International Journal of Molecular Sciences;2023-11-06
3. Deciphering the Role of Selenoprotein M;Antioxidants;2023-10-25
4. SELENOM Knockout Induces Synaptic Deficits and Cognitive Dysfunction by Influencing Brain Glucose Metabolism;Journal of Agricultural and Food Chemistry;2023-01-12
5. How is the AKT/mTOR pathway involved in cell migration and invasion?;BIOCELL;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3